COVID-19 in a patient with Good's syndrome and in 13 patients with common variable immunodeficiency.
Clin Immunol Commun
; 1: 20-24, 2021 Dec.
Article
en En
| MEDLINE
| ID: mdl-38620775
ABSTRACT
Antibody deficiencies constitute the majority of primary immunodeficiencies in adults. These patients have a well-established increased risk of bacterial infections but there is a lack of knowledge regarding the relative risks upon contracting COVID-19. In this monocentric study the disease course of COVID-19 in 1 patient with Good's syndrome and in 13 patients with common variable immunodeficiency (CVID) is described. The severity of disease ranged from very mild to severe. Several patients required hospitalization and immunomodulatory treatment but all survived. Although viral infections are not a typical feature of humoral immunodeficiencies we recommend that vigilance is increased in the management of patients with Good's syndrome and CVID during the COVID-19 pandemic.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Clin Immunol Commun
Año:
2021
Tipo del documento:
Article
País de afiliación:
Suecia